These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2874977)

  • 1. Current management of Zollinger-Ellison syndrome.
    Jensen RT; Maton PN; Gardner JD
    Drugs; 1986 Aug; 32(2):188-96. PubMed ID: 2874977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of acid suppressants in patients with Zollinger-Ellison syndrome.
    Maton PN
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():25-35. PubMed ID: 1679671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Maton PN; Gardner JD; Jensen RT
    Gastroenterol Clin North Am; 1989 Dec; 18(4):847-63. PubMed ID: 2575602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Zollinger-Ellison syndrome with exploratory laparotomy, proximal gastric vagotomy, and H2-receptor antagonists. A prospective study.
    Richardson CT; Peters MN; Feldman M; McClelland RN; Walsh JH; Cooper KA; Willeford G; Dickerman RM; Fordtran JS
    Gastroenterology; 1985 Aug; 89(2):357-67. PubMed ID: 2861140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients with Zollinger-Ellison syndrome.
    Meko JB; Norton JA
    Annu Rev Med; 1995; 46():395-411. PubMed ID: 7598474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of the Zollinger-Ellison syndrome.
    Jensen RT; Pandol SJ; Collen MJ; Raufman JP; Gardner JD
    J Clin Gastroenterol; 1983; 5 Suppl 1():123-31. PubMed ID: 6140281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zollinger-Ellison syndrome. Recognition and management of acid hypersecretion.
    Maton PN
    Drugs; 1996 Jul; 52(1):33-44. PubMed ID: 8799683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome.
    Metz DC; Pisegna JR; Fishbeyn VA; Benya RV; Jensen RT
    World J Surg; 1993; 17(4):468-80. PubMed ID: 8362529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Zollinger-Ellison syndrome].
    Duek SD; Barzilai A
    Harefuah; 1991 Apr; 120(7):384-5. PubMed ID: 1679028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: the management of Zollinger-Ellison syndrome.
    Maton PN
    Aliment Pharmacol Ther; 1993 Oct; 7(5):467-75. PubMed ID: 7904187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.
    Tomassetti P; Salomone T; Migliori M; Campana D; Corinaldesi R
    Drugs Aging; 2003; 20(14):1019-34. PubMed ID: 14651442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zollinger-Ellison syndrome (gastrinoma). Current diagnosis and treatment.
    Deveney CW; Deveney KE
    Surg Clin North Am; 1987 Apr; 67(2):411-22. PubMed ID: 2882614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the Zollinger-Ellison syndrome in pregnancy.
    Stewart CA; Termanini B; Sutliff VE; Corleto VD; Weber HC; Gibril F; Jensen RT
    Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):224-33. PubMed ID: 9024119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of perioperative and postoperative control of acid hypersecretion in patients with Zollinger-Ellison syndrome undergoing gastrinoma resection.
    Fraker DL; Norton JA; Saeed ZA; Maton PN; Gardner JD; Jensen RT
    Surgery; 1988 Dec; 104(6):1054-63. PubMed ID: 2904182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of proton pump inhibitor to special conditions; Zollinger-Ellison syndrome].
    Tani N
    Nihon Rinsho; 1992 Jan; 50(1):154-9. PubMed ID: 1347327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Famotidine: effective treatment of Zollinger-Ellison syndrome.
    Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
    J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers.
    Meijer JL; Jansen JB; Lamers CB
    Digestion; 1989; 44 Suppl 1():31-9. PubMed ID: 2575060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Vinayek R; Hahne WF; Euler AR; Norton JA; Jensen RT
    Dig Dis Sci; 1993 Oct; 38(10):1857-65. PubMed ID: 8104773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Famotidine in the therapy of gastric hypersecretory states.
    Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
    Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.